195 related articles for article (PubMed ID: 18221064)
1. Potassium channels are a new target field in anticancer drug design.
Villalonga N; Ferreres JC; Argilés JM; Condom E; Felipe A
Recent Pat Anticancer Drug Discov; 2007 Nov; 2(3):212-23. PubMed ID: 18221064
[TBL] [Abstract][Full Text] [Related]
2. Potassium channels: novel emerging biomarkers and targets for therapy in cancer.
D'Amico M; Gasparoli L; Arcangeli A
Recent Pat Anticancer Drug Discov; 2013 Jan; 8(1):53-65. PubMed ID: 22574647
[TBL] [Abstract][Full Text] [Related]
3. Targeting the voltage-dependent K(+) channels Kv1.3 and Kv1.5 as tumor biomarkers for cancer detection and prevention.
Felipe A; Bielanska J; Comes N; Vallejo A; Roig S; Ramón Y Cajal S; Condom E; Hernández-Losa J; Ferreres JC
Curr Med Chem; 2012; 19(5):661-74. PubMed ID: 22204339
[TBL] [Abstract][Full Text] [Related]
4. Correlation between potassium channel expression and sensitivity to drug-induced cell death in tumor cell lines.
Leanza L; O'Reilly P; Doyle A; Venturini E; Zoratti M; Szegezdi E; Szabo I
Curr Pharm Des; 2014; 20(2):189-200. PubMed ID: 23701546
[TBL] [Abstract][Full Text] [Related]
5. Targeting K+ channels for cancer therapy.
Conti M
J Exp Ther Oncol; 2004 Jul; 4(2):161-6. PubMed ID: 15500011
[TBL] [Abstract][Full Text] [Related]
6. Involvement of potassium channels in the progression of cancer to a more malignant phenotype.
Comes N; Serrano-Albarrás A; Capera J; Serrano-Novillo C; Condom E; Ramón Y Cajal S; Ferreres JC; Felipe A
Biochim Biophys Acta; 2015 Oct; 1848(10 Pt B):2477-92. PubMed ID: 25517985
[TBL] [Abstract][Full Text] [Related]
7. The need for calcium channels in cell proliferation.
Capiod T
Recent Pat Anticancer Drug Discov; 2013 Jan; 8(1):4-17. PubMed ID: 22519598
[TBL] [Abstract][Full Text] [Related]
8. K(+) channels as therapeutic targets in oncology.
Stühmer W; Pardo LA
Future Med Chem; 2010 May; 2(5):745-55. PubMed ID: 21426201
[TBL] [Abstract][Full Text] [Related]
9. Potassium channel blockers and openers as CNS neurologic therapeutic agents.
Judge SI; Smith PJ; Stewart PE; Bever CT
Recent Pat CNS Drug Discov; 2007 Nov; 2(3):200-28. PubMed ID: 18221232
[TBL] [Abstract][Full Text] [Related]
10. Calcium channels and prostate cancer.
Shapovalov G; Skryma R; Prevarskaya N
Recent Pat Anticancer Drug Discov; 2013 Jan; 8(1):18-26. PubMed ID: 22694290
[TBL] [Abstract][Full Text] [Related]
11. Current strategies for the discovery of K+ channel modulators.
Ye D; Wang J; Yu K; Zhou Y; Jiang H; Chen K; Liu H
Curr Top Med Chem; 2009; 9(4):348-61. PubMed ID: 19442206
[TBL] [Abstract][Full Text] [Related]
12. Functional role of Kv1.1 and Kv1.3 channels in the neoplastic progression steps of three cancer cell lines, elucidated by scorpion peptides.
Aissaoui D; Mlayah-Bellalouna S; Jebali J; Abdelkafi-Koubaa Z; Souid S; Moslah W; Othman H; Luis J; ElAyeb M; Marrakchi N; Essafi-Benkhadir K; Srairi-Abid N
Int J Biol Macromol; 2018 May; 111():1146-1155. PubMed ID: 29415410
[TBL] [Abstract][Full Text] [Related]
13. Targeting potassium channels: new advances in cardiovascular therapy.
Martínez-Mármol R; Roura-Ferrer M; Felipe A
Recent Pat Cardiovasc Drug Discov; 2008 Jun; 3(2):105-18. PubMed ID: 18537761
[TBL] [Abstract][Full Text] [Related]
14. Researches toward potassium channels on tumor progressions.
Shen Z; Yang Q; You Q
Curr Top Med Chem; 2009; 9(4):322-9. PubMed ID: 19442203
[TBL] [Abstract][Full Text] [Related]
15. Targeting potassium channels in cancer.
Huang X; Jan LY
J Cell Biol; 2014 Jul; 206(2):151-62. PubMed ID: 25049269
[TBL] [Abstract][Full Text] [Related]
16. Pharmacology of cardiac potassium channels.
Li GR; Dong MQ
Adv Pharmacol; 2010; 59():93-134. PubMed ID: 20933200
[TBL] [Abstract][Full Text] [Related]
17. Theoretical possibilities for the development of novel antiarrhythmic drugs.
Varró A; Biliczki P; Iost N; Virág L; Hála O; Kovács P; Mátyus P; Papp JG
Curr Med Chem; 2004 Jan; 11(1):1-11. PubMed ID: 14754422
[TBL] [Abstract][Full Text] [Related]
18. Targeting ion channels for cancer therapy by repurposing the approved drugs.
Kale VP; Amin SG; Pandey MK
Biochim Biophys Acta; 2015 Oct; 1848(10 Pt B):2747-55. PubMed ID: 25843679
[TBL] [Abstract][Full Text] [Related]
19. Medicinal Chemistry of Potassium Channel Modulators: An Update of Recent Progress (2011-2017).
Vyas VK; Parikh P; Ramani J; Ghate M
Curr Med Chem; 2019; 26(12):2062-2084. PubMed ID: 29714134
[TBL] [Abstract][Full Text] [Related]
20. Voltage-Gated Potassium Channels Kv1.3--Potentially New Molecular Target in Cancer Diagnostics and Therapy.
Teisseyre A; Gąsiorowska J; Michalak K
Adv Clin Exp Med; 2015; 24(3):517-24. PubMed ID: 26467143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
